Compounded Semaglutide: 2026 Guide

Compounded semaglutide is the active ingredient in Ozempic, Wegovy, and Rybelsus, prepared by a licensed US compounding pharmacy and prescribed by a clinician. Cash-pay pricing is typically $199–399 per month — significantly less than brand. Here is how it works and what to know.

Last updated May 1, 2026 · Researched and written by the GLP Insights editorial team.

What Is Compounded Semaglutide?

Compounded semaglutide is a customized preparation of the semaglutide active ingredient, produced by a state-licensed compounding pharmacy under a US clinician's prescription for an individual patient. It is the same molecule that appears in Novo Nordisk's branded products (Ozempic, Wegovy, Rybelsus). It is not made by Novo Nordisk and does not carry their brand labeling.

Some compounded formulations add B12 (cyanocobalamin), L-carnitine, or other supportive ingredients. Pure semaglutide is also available; the choice depends on prescriber preference and pharmacy practice.

Is Compounded Semaglutide Legal?

Compounded semaglutide is legal in the US when prepared by a state-licensed 503A pharmacy or registered 503B outsourcing facility, for an individual patient, with a valid prescription. Federal law permits compounding when the corresponding FDA-approved drug is on the Drug Shortage list (or for specific clinical reasons even outside of shortage, in some 503A cases).

FDA shortage status changes. Semaglutide was on the FDA shortage list for a sustained period and has had its status updated multiple times in recent years. Reputable telehealth platforms adjust their compounded offerings based on current FDA status. Always verify current status on the FDA Drug Shortages database.

Compounded vs Brand: Side-by-Side

Why Compounded Costs Less

• No brand-name pricing premium or marketing overhead
• Vial-and-syringe format is cheaper than auto-injector pens
• Direct-to-consumer telehealth subscription model removes pharmacy retail markup
• Sourced API in bulk at lower per-unit cost

Safety: How to Verify Sourcing

Compounded medications carry risks distinct from FDA-approved drugs. Look for:

• Pharmacy licensure visible on the platform
• PCAB accreditation or USP <797> compliance
• API from an FDA-registered facility
• Prescription required from a US-licensed clinician in your state
• Avoid "semaglutide sodium" or "research only" labels — FDA has warned that these are not legitimate semaglutide for human use

How to Get Compounded Semaglutide

1. Pick a telehealth platform that publishes its compounding pharmacy details (Hers, Ro Body, Mochi, Fridays, and Noom Med are common options)
2. Complete the medical intake form online
3. Have a video consult with a licensed clinician in your state
4. If eligible, receive the prescription and shipment (typically 7–10 business days)
5. Monthly follow-ups for dose adjustment and side-effect management

Who Compounded Semaglutide Suits Best

Good candidates: Cash-paying adults with BMI 30+, or 27+ with type 2 diabetes, hypertension, sleep apnea, or other weight-related condition, who do not have insurance coverage for brand-name GLP-1.

Not appropriate: People with a personal or family history of medullary thyroid carcinoma, MEN-2, pancreatitis, pregnancy, or severe GI disease such as gastroparesis. People with full insurance coverage for brand semaglutide may prefer the regulated FDA-approved product.

Common Red Flags

• Sites selling "peptide semaglutide" without requiring a prescription
• "Research chemical" or "for laboratory use only" labeling
• Prices below $150/month (often counterfeit or unsafe formulations)
• No clinician contact and no published pharmacy
• Imports from outside the US

Related Reading

• All About Semaglutide
• Compounded Tirzepatide
• Full GLP-1 Cost Breakdown
• How to Get GLP-1 Online
• Is There a Generic Ozempic?

Sources

• FDA Drug Shortages list. accessdata.fda.gov
• FDA compounding guidance under FD&C Act sections 503A and 503B.
• Semaglutide FDA prescribing information (Ozempic, Wegovy, Rybelsus).
• Wilding et al. STEP-1 trial. N Engl J Med 2021.